Artificial Organs and Bionics Market Size, Share, Growth, Forecast and Trends 2023-2031: Additional Growth Reports (2023)

Report overview

According to the Deep Dive market valuation study conducted by Growth Plus Reports, the global market for artificial and bionic organs was valued at USD 27.6 billion in 2022.

Market basics

The artificial and bionic organ market is a dynamic and rapidly growing area driven by advances in biomedical engineering, materials science and robotics. The market is expected to continue to grow in the coming years, driven by increased demand for these technologies as the world's population ages and the prevalence of chronic diseases such as diabetes, heart and kidney disease increases. The artificial organs market includes a wide range of products including heart valves, artificial kidneys, liver assist devices and more. The bionics market includes products such as prostheses, cochlear implants, exoskeletons, and other devices that enhance or enhance the function of natural body parts.

The market for artificial and bionic organs is very competitive and many companies are investing in research and development to create new and innovative products. Major market players include Abiomed Inc., Medtronic, Abbott Laboratories, Boston Scientific Corporation, Cochlear Limited, and Ekso Bionics, among others.

Despite the positive perspectives, the market for artificial and bionic organs still faces challenges that need to be faced. These challenges include ensuring the safety and effectiveness of these devices, meeting regulatory requirements, and improving patient affordability and affordability. However, continued investments in R&D are expected to drive innovation and new product development, which will further drive market growth.

Artificial organs and bionics are areas of biomedical engineering that involve the development of devices to replace or enhance the function of organs or body parts. Artificial organs are devices that mimic the function of natural organs such as the heart, lungs, liver or kidneys. . They are typically made from biocompatible materials and can be powered by electricity, batteries and other energy sources. Examples of artificial organs includepacemaker, artificial hearts and kidney dialysis machines. Bionics, on the other hand, involves the development of devices that increase or enhance the function of natural parts of the body. Bionic devices can be controlled by the nervous system or other biological signals, allowing humans to perform tasks that would otherwise be impossible. Examples of bionic devices are prostheses, cochlear implants and exoskeletons.

[57657]

market dynamics

The global prevalence of chronic diseases such as diabetes, heart and kidney disease is increasing, driving demand for artificial and bionic organs as treatment options. According to the National Center for Biotechnology Information, chronic kidney disease affects more than 10% of the general population worldwide, representing more than 800 million people. Advances in areas such as biomedical engineering, materials science and robotics are allowing the development of increasingly sophisticated artificial and bionic organs, improving their efficiency and reliability, driving the growth of artificial and bionic organs.Market. AI is being used to improve the accuracy and effectiveness of artificial and bionic organs, helping to predict and prevent complications and optimize performance. Advances in surgical techniques have led to the development of minimally invasive methods of implanting artificial and bionic organs, reducing risks and patient recovery time, which also increases the demand for artificial and bionic organs.

Beside,With the proliferation of genetic testing and other approaches to personalized medicine, artificial and bionic organs are being tailored to the unique needs of individual patients, leading to better outcomes. The growing geriatric population is also driving demand for artificial organs, and bionics are expected to increase as age-related diseases and conditions become more common. The shortage of donor organs for transplantation is driving the development of artificial organs that may provide a life-saving alternative for patients in need. Furthermore, the growing awareness of the potential benefits of artificial and bionic organs and the growing acceptance of this technology are expected to drive the growth of artificial and bionic organs.Market. However, artificial and bionic organs are expensive, which limits the market for artificial and bionic organs.Market. Safety and efficacy concerns can be a significant barrier to widespread adoption of artificial and bionic organs. The risk of infection, rejection, and other complications associated with using these devices can further compound these concerns. There are ethical concerns related to the use of artificial and bionic organs, such as B. Issues related to quality of life, patient autonomy and resource allocation, which are also expected to hinder the growth of artificial and bionic organs worldwide.Mercado.

market ecosystem

Global artificial organs and bionics.The market is analyzed from four perspectives: product, technology and region.

Artificial and Bionic Organs Market by Product

[86565]

Based on the product, global and bionic artificial organs.The market is segmented into artificial organs and artificial bionics.

The artificial organ segment has been dominated by artificial and bionic organs.Market with a significant share of sales. The segment of artificial organs is further divided into heart, liver, kidney, lung and pancreas. There is a significant shortage of donor organs available for transplantation, which has increased the demand for artificial organs as a viable alternative. According to the Health Services and Resources Administration, more than 106,000 people are currently on the national transplant waiting list in the United States. Technological advances have greatly improved the safety and efficiency of artificial organs, making them a very attractive alternative for patients. For example, the development of biocompatible materials and improvements in surgical techniques have greatly increased the reliability and effectiveness of artificial organs. Personalized medicine tailored to the different needs of each patient is gaining momentum, and artificial organs can be tailored to patients' specific needs, leading to better treatment outcomes and greater patient satisfaction. As the world's population ages, age-related diseases such as diabetes, kidney and heart disease increase, resulting in increased demand for artificial organs, especially among elderly patients who may not be suitable for traditional organ transplants.

The artificial bionics segment is expected to experience a profitable growth rate during the forecast period. The development of technology has facilitated the development of bionic prostheses that can mimic the functionality of natural limbs, responding to and sensing the environment, leading to increased demand among amputees and people with limb disabilities. Furthermore, the increasing prevalence of chronic diseases such as diabetes, cardiovascular disease and cancer has spurred the need for implantable devices.medical equipmentthat can replace or support damaged organs or bodily functions. Bionic implants, such as artificial hearts, pacemakers, and cochlear implants, can restore normal bodily functions, prolong life expectancy, and improve the quality of life for patients with chronic illnesses. In addition, the increasing use of 3D printing technology in the manufacture of artificial and bionic organs has reduced production costs, reduced time to market and allowed mass customization of these devices. As a result, medical device manufacturers can develop more innovative and affordable bionics products that meet the diverse needs of patients, fueling the expansion of the artificial bionics segment.

Artificial and Bionic Organs Market by Technology

Based on technology, global artificial organs and bionics.The market is divided into mechanics and electronics.

The mechanical segment accounted for a significant portion of global sales of artificial and bionic organs.Market. Mechanical devices have been around longer than other types of artificial and bionic organs. This has led to a better understanding of the technology, more clinical research, and a greater number of successful mechanical implants in patients. Furthermore, mechanical devices are easier to manufacture, maintain and repair compared to other types of artificial and bionic organs, making them more affordable and available in regions with limited access to advanced medical technology. In addition, mechanical devices can perform vital functions, such as B. pumping blood through an artificial heart or supporting the knee joint with an artificial knee. These devices have improved the quality of life and increased the chances of survival for thousands of patients with life-threatening illnesses or disabilities. The mechanical segment of the bionic and artificial organs market has leveraged advances in materials science, robotics and miniaturization technology to create more sophisticated and reliable devices, including ventricular assist devices, heart valves and joint replacements. These devices offer greater durability, better performance and fewer complications for patients.

The electronics segment is expected to have the fastest growth rate in the artificial and bionic organ market. The use of cutting-edge electronic and software technology has facilitated the creation of sophisticated and adaptable devices that can interact with the human body. An example of such a device is electronic prostheses, which can sense muscle movement and adjust accordingly, improving the wearer's mobility and dexterity. The reduced cost of electronic components and miniaturization technology have made it feasible to manufacture smaller and more complicated electronic devices. This development has opened up new opportunities for medical device manufacturers to create more creative and affordable electronics that meet the diverse needs of patients, driving growth in the electronics segment. Increased funding for medical electronic device research and development has led to remarkable achievements in the industry. Among them are the innovation of neurostimulators for the treatment of chronic pain and hearing implants for the deaf, which continue to drive the growth of the electronic segment in the market for artificial and bionic organs.

Bionics and Artificial Organs Market by Regions

Geographically, the global artificial and bionic organs market has been segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

The North America region accounted for a significant share of the market's revenue in 2022. The North America region is known for its strong focus on healthcare research and development, which has led to the introduction of new and innovative organ products bionic and artificial. The rising prevalence of chronic diseases such as cancer, cardiovascular disease and diabetes has increased the demand for implantable medical devices that can replace or support damaged organs or bodily functions. The 2022 National Diabetes Statistics Report from the Centers for Disease Control and Prevention shows that approximately 130 million adults in the United States currently have diabetes or pre-diabetes. The region's government heavily subsidizes healthcare and has favorable reimbursement policies for medical devices, improving the affordability and affordability of artificial and bionic organs and encouraging healthcare professionals to use them.

competitive scenario

Top listed manufacturers for global Bionics and Artificial Organs Market are:

• Abbott Labors
• Abiomed Inc.
• medtronic plc
• Boston Scientific Corporation
• limited cochlea
• Ekso Bionic
• ZimmerBiomet
• heart of berlin ltd
• Edward Lifesciences Corporation
• baxter
• Heartware International, Inc.
• iwalk, inc.

Strategic Developments

• In August 2022, MIT researchers developed a method that could be used to ensure long-lasting implants of medical devices do not trigger an immune response. The goal of her research is to allow the implants to continue working without being rejected by the body. To overcome this foreign body reaction, MIT researchers built a soft robotic device that can inflate and deflate. Every 12 hours, the implant is allowed to rapidly expand and contract to remove immune cell buildup.
• In January 2022, IT-Kanpur started a project to develop an advanced artificial heart. Led by a task force of industry experts, a team of experienced innovators was selected to lead the development of an advanced artificial heart project in collaboration with several hospitals in India.

Frequently asked questions about this report

Index

1. INTRODUCTION
   1. market ecosystem
   2. timeline in consideration
      1. Historical years - 2021
      2. Base year â 2022
      3. Forecast years - 2023 to 2031
   3. Currency used in the report
2. RESEARCH METHODOLOGY
   1. research focus
   2. Data collection methodology
   3. data products
      1. secondary products
      2. primary products
   4. Approach to market estimation
      1. Prost
      2. Bald
   5. MarketForecastModel
   6. Limitations and Assumptions
3. PREMIUM PERSPECTIVES
   1. Current market trends (COVID-19 perspective)
   2. Key players and competitive positioning (2022)
   3. regulatory landscape
   4. refund scenario
4. MARKET DYNAMICS
   1. driver
   2. Limitations/Challenges
   3. occasions
5. ANALYSIS AND FORECAST OF THE WORLD MARKET FOR ARTIFICIAL AND BIONIC ORGANS BY PRODUCT
   1. artificial organ
      1. herz
      2. Leber
      3. Rins
      4. Thrust
      5. pancreas
   2. artificial bionics
      1. bionic limbs
      2. bionic vision
      3. cochlear implant
      4. exoskeleton
      5. brain bionics
6. WORLD MARKET FOR ARTIFICIAL AND BIONIC ORGANS: ANALYSIS AND FORECAST BY TECHNOLOGY
   1. mechanic
   2. electronic
7. GLOBAL MARKET FOR ARTIFICIAL AND BIONIC ORGANS: ANALYSIS AND FORECAST BY REGION
   1. Market for artificial and bionic organs in North America
      1. North American Artificial and Bionic Organs Market by Product
      2. North American Artificial and Bionic Organs Market by Technology
      3. North American Artificial and Bionic Organs Market by Country
         1. US.
            1. US Bionics & Artificial Organs Market by Product
            2. US Bionics & Artificial Organs Market, by technology
         2. You have
            1. Canadian Bionics & Artificial Organs Market by Product
            2. Canada Bionics & Artificial Organs Market by Technology
   2. European market for artificial and bionic organs
      1. Europe Artificial Organs and Bionics Market, by Product
      2. European market for artificial and bionic organs by technology
      3. European Artificial and Bionic Organs Market by Country or Region
         1. Germany
            1. German Bionic and Artificial Organs Market by Product
            2. Germany Bionic & Artificial Organ Market by Technology
         2. GREAT BRITAIN.
            1. UK Bionics & Artificial Organs Market by Product
            2. UK Bionics & Artificial Organs Market by Technology
         3. France
            1. Market for artificial and bionic organs in France, by product
            2. France Artificial and bionic organs market by technology
         4. Spain
            1. Market for Artificial and Bionic Organs in Spain, by Product
            2. Market for artificial and bionic organs in Spain, by technology
         5. Italy
            1. Italian Bionics and Artificial Organs Market, by Product
            2. Italy Bionics & Artificial Organs Market by Technology
         6. rest from Europe
            1. Market for Artificial and Bionic Organs in Rest of Europe by Product
   3. Rest of Europe artificial and bionic organ market, by technology
   4. Bionics and Artificial Organs Market in Asia Pacific
      1. Asia Pacific Artificial and Bionic Organs Market by Product
      2. Asia Pacific Artificial & Bionic Organ Market by Technology
      3. Asia Pacific Bionics & Artificial Organs Market by Country/Region
         1. porcelain
            1. China Bionics & Artificial Organs Market by Product
            2. Bionics & Artificial Organs Market in China by Technology
         2. Japan
            1. Japan Artificial and Bionic Organs Market by Product
            2. Japan Artificial and Bionic Organ Market by Technology
         3. Se
            1. Bionics & Artificial Organs Market in India by Product
            2. India Bionics and Artificial Organ Market by Technology
         4. South Korea
            1. South Korean Bionics & Artificial Organs Market by Product
            2. South Korea's Bionics & Artificial Organs Market, by technology
         5. Australia
            1. Australian Bionics & Artificial Organs Market by Product
            2. Australian bionic and artificial organs market by technology
         6. Rest of Asia Pacific
            1. Rest of Asia-Pacific Artificial Organs and Bionics Market, by Product
            2. Rest of Asia-Pacific Artificial Organs and Bionics Market, by Technology
   5. Latin American market for artificial and bionic organs
      1. Artificial and Bionic Organs Market in Latin America, by Product
      2. Latin America Artificial and Bionic Organ Market by Technology
      3. Artificial and Bionic Organs Market in Latin America, by Country/Region
         1. Brazil
            1. Artificial and bionic organs market in Brazil, by product
            2. Market for Artificial and Bionic Organs in Brazil, by Technology
         2. Mexico
            1. Mexican Artificial and Bionic Organs Market by Product
            2. Market for artificial and bionic organs in Mexico, by technology
         3. Argentina
            1. Artificial and bionic organs market in Argentina, by product
            2. Argentine market for artificial and bionic organs, by technology
         4. Rest of Latin America
            1. Rest of Latin America Artificial and Bionic Organs Market, by Product
            2. Rest of Latin America Artificial and Bionic Organ Market, by Technology
   6. Bionics and Artificial Organs Market in the Middle East and Africa
      1. Middle East and Africa Artificial and Bionic Organs Market by Product
      2. Middle East and Africa Bionics and Artificial Organ Market by Technology
      3. Middle East and Africa Artificial and Bionic Organs Market by Country/Region
         1. GCC countries
            1. Artificial and Bionic Organs Market of GCC Countries by Product
            2. Artificial and Bionic Organ Market in GCC Countries by Technology
         2. South Africa
            1. South African Bionics and Artificial Organs Market by Product
            2. South African Bionics & Artificial Organs Market, by Technology
         3. Rest of Middle East and Africa
            1. Remaining Market for Artificial and Bionic Organs in the Middle East and Africa, by Product
            2. Rest of Middle East and Africa Bionic & Artificial Organ Market, by technology
8. COMPANY PROFILES
   1. Abbott Labors
      1. business snapshot
      2. products offered
      3. financial details
      4. strategic development
   2. Abiomed Inc.
   3. medtronic plc
   4. Boston Scientific Corporation
   5. limited cochlea
   6. Ekso Bionic
   7. ZimmerBiomet
   8. heart of berlin ltd
   9. Edward Lifesciences Corporation
   10. baxter
   11. Heartware International, Inc.
   12. iwalk, inc.

*Forecasts of financial performance are subject to availability of public domain information

table list

1. Global Bionics and Artificial Organs Market, by Product, 2021-2031 (Million USD)
2. Global Bionics and Artificial Organs Market by Technology, 2021-2031 (Million USD)
3. Global Artificial and Bionic Organs Market, by Region, 2021-2031 (US$ Million)
4. North America Artificial and Bionic Organs Market by Product, 2021-2031 (US$ Million)
5. North American Artificial and Bionic Organ Market, by Technology, 2021-2031 ($M)
6. North American Artificial and Bionic Organ Market by Country, 2021-2031 (US$ Million)
7. US Bionic and Artificial Organ Market, by Product, 2021-2031 (US$ Million)
8. US Bionic & Artificial Organ Market, by Technology, 2021-2031 ($M)
9. Canadian Bionic and Artificial Organs Market, by Product, 2021-2031 (US$ Million)
10. Canadian Bionic & Artificial Organ Market, by Technology, 2021-2031 (US$ Million)
11. European Artificial and Bionic Organs Market, by Product, 2021-2031 (US$ Million)
12. European market for artificial and bionic organs, by technology, 2021-2031 (US$ million)
13. European market for artificial and bionic organs, by country/region, 2021-2031 (millions of dollars)
14. German Bionic and Artificial Organs Market, by Product, 2021-2031 ($M)
15. German Bionic and Artificial Organ Market, by Technology, 2021-2031 ($M)
16. UK Artificial and Bionic Organs Market, by Product, 2021-2031 ($M)
17. UK Bionic & Artificial Organ Market, by Technology, 2021-2031 ($M)
18. France Artificial and Bionic Organ Market by Product, 2021-2031 (US$ Million)
19. French Bionic and Artificial Organ Market, by Technology, 2021-2031 ($M)
20. Italy Artificial and Bionic Organs Market, by Product, 2021-2031 (USD Mn)
21. Italian Artificial and Bionic Organ Market, by Technology, 2021-2031 ($M)
22. Market for artificial and bionic organs in Spain by product, 2021-2031 (million US$)
23. Artificial and Bionic Organ Market in Spain, by Technology, 2021-2031 (US$ Million)
24. Rest of Europe Artificial and Bionic Organ Market, by Product, 2021-2031 (US$ Million)
25. Rest of Europe Artificial and Bionic Organ Market, by Technology, 2021-2031 ($M)
26. Asia-Pacific Artificial and Bionic Organs Market, by Product, 2021-2031 (US$ Million)
27. Asia-Pacific Bionics & Artificial Organs Market, by Technology, 2021-2031 (US$ Million)
28. Asia-Pacific Artificial and Bionic Organs Market, by Country/Region, 2021-2031 (USD Million)
29. Artificial and Bionic Organ Market in China, by Product, 2021-2031 (US$ Million)
30. China Artificial and Bionic Organ Market, by Technology, 2021-2031 (US$ Million)
31. Japan Artificial and Bionic Organ Market, by Product, 2021-2031 (US$ Million)
32. Japan Artificial and Bionic Organ Market, by Technology, 2021-2031 (US$ Million)
33. India Bionic & Artificial Organs Market, by Product, 2021-2031 (US$ Million)
34. India's Bionic & Artificial Organs Market, by Technology, 2021-2031 (US$ Million)
35. South Korea Artificial and Bionic Organs Market, by Product, 2021-2031 (US$ Million)
36. South Korea Artificial and Bionic Organ Market, by Technology, 2021–2031 ($M)
37. Australian Artificial and Bionic Organs Market, by Product, 2021-2031 (US$ Million)
38. Australian Artificial and Bionic Organ Market, by Technology, 2021-2031 (US$ Million)
39. Rest of Asia Pacific Artificial and Bionic Organs Market, by Product, 2021-2031 (US$ Million)
40. Rest of Asia-Pacific Artificial and Bionic Organ Market, by Technology, 2021-2031 (in millions of dollars)
41. Latin America Artificial and Bionic Organs Market by Product, 2021-2031 (US$ Million)
42. Latin American Artificial and Bionic Organ Market, by Technology, 2021-2031 (US$ Million)
43. Latin America Artificial and Bionic Organs Market, by Country/Region, 2021-2031 (in millions of US dollars)
44. Brazilian Artificial and Bionic Organs Market, by Product, 2021-2031 (US$ Million)
45. Brazilian bionics and artificial organs market, by technology, 2021-2031 (million US$)
46. Market for Artificial and Bionic Organs in Mexico, by Product, 2021-2031 (US$ Million)
47. Market for artificial and bionic organs in Mexico, by technology, 2021-2031 (US$ million)
48. Argentine market for artificial and bionic organs, by product, 2021-2031 (US$ million)
49. Argentina Artificial and Bionic Organ Market, by Technology, 2021–2031 (US$ Million)
50. Rest of Latin America Artificial and Bionic Organs Market, by Product, 2021-2031 (US$ Million)
51. Rest of Latin America Artificial and Bionic Organ Market, by Technology, 2021-2031 (US$ Million)
52. Middle East and Africa Artificial and Bionic Organs Market, by Product, 2021-2031 (USD Million)
53. Artificial and Bionic Organ Market in the Middle East and Africa, by Technology, 2021-2031 (US$ Million)
54. Artificial and Bionic Organs Market, Middle East and Africa, by Country/Region, 2021-2031 (USD Million)
55. Artificial and Bionic Organ Market of GCC Countries, by Product, 2021-2031 (US$ Million)
56. GCC Artificial and Bionic Organ Market by Technology, 2021-2031 ($M)
57. South African Bionics & Artificial Organs Market, by Product, 2021-2031 (USD Mn)
58. South Africa Artificial and Bionic Organ Market, by Technology, 2021-2031 (US$ Million)
59. Rest of Middle East and Africa Bionics and Artificial Organs Market, by Product, 2021-2031 (USD Million)
60. Rest of Middle East and Africa Bionic and Artificial Organs Market, by Technology, 2021-2031 ($M)
61. Rest of Middle East and Africa Bionic and Artificial Organs Market, by Technology, 2021-2031 ($M)

List of figures

1. Artificial organs and bionic market ecosystem
2. Global Artificial and Bionic Organs Market Snapshot, 2021-2031
3. Global Artificial and Bionic Organs Market Snapshot by Region, 2021-2031
4. Global Artificial and Bionic Organs Market: Assessing the Impact of the COVID-19 Pandemic
5. Global Bionics and Artificial Organs Market: Key Players and Competitive Positioning (2022)
6. Artificial organs and bionics: market dynamics
7. Global Artificial Organs and Bionics for Artificial Organs Market, 2021-2031 (US$ Million)
8. Global Cardiac Bionics and Artificial Organs Market, 2021-2031 (Million USD)
9. Global Liver Bionics and Artificial Organs Market, 2021-2031 (US$ Million)
10. World market for renal bionics and artificial organs, 2021-2031 (millions of dollars)
11. Global Bionic Lung and Artificial Organs Market, 2021-2031 (Million USD)
12. Global Artificial and Bionic Organs for Pancreas Market, 2021-2031 (US$ Million)
13. Global Artificial Organs and Bionics Market, 2021-2031 (Million USD)
14. Global Artificial and Bionic Organs of Bionic Limbs Market, 2021-2031 (US$ Million)
15. Global Bionics and Artificial Organs for Bionic Vision Market, 2021-2031 (Million USD)
16. Global Artificial Organs and Bionics Market for Cochlear Implants, 2021-2031 (Million USD)
17. Global Artificial Organs and Bionics for Exoskeleton Market, 2021-2031 (US$ Million)
18. Global Bionics and Brain Bionics Artificial Organs Market, 2021-2031 (US$ Million)
19. Global Artificial Organs and Bionics for Mechanics Market, 2021-2031 (US$ Million)
20. Global Artificial Organs and Bionics to Electronics Market, 2021-2031 (US$ Million)
21. North American Artificial and Bionic Organ Market, 2021-2031 (US$ Million)
22. US Bionics and Artificial Organs Market, 2021-2031 (US$ Million)
23. Canadian Bionics and Artificial Organs Market, 2021-2031 (US$ million)
24. European market for artificial and bionic organs, 2021-2031 (US$ million)
25. German Bionics and Artificial Organs Market, 2021-2031 (US$ million)
26. UK bionic and artificial organ market, 2021-2031 (in millions of dollars)
27. France Market for artificial and bionic organs, 2021-2031 (millions of dollars)
28. Bionics and artificial organs market in Italy, 2021-2031 (millions of dollars)
29. Market for artificial and bionic organs in Spain, 2021-2031 (US$ million)
30. Rest of Europe Artificial and Bionic Organ Market, 2021-2031 (US$ million)
31. Asia-Pacific Artificial and Bionic Organ Market, 2021-2031 (US$ Million)
32. Bionics and artificial organs market in China, 2021-2031 (US$ million)
33. Japan Bionic and Artificial Organ Market, 2021-2031 (US$ Million)
34. Indian Artificial and Bionic Organ Market, 2021-2031 (US$ Million)
35. South Korean bionics and artificial organs market, 2021-2031 (US$ million)
36. Australian bionics and artificial organs market, 2021-2031 (millions of dollars)
37. Rest of Asia-Pacific Artificial and Bionic Organ Market, 2021-2031 (US$ Million)
38. Market for artificial and bionic organs in Latin America, 2021-2031 (US$ million)
39. Market for artificial and bionic organs in Brazil, 2021-2031 (US$ million)
40. Market for artificial and bionic organs in Mexico, 2021-2031 (US$ million)
41. Artificial and bionic organs market in Argentina, 2021-2031 (US$ million)
42. Rest of Latin America, Artificial and Bionic Organs Market, 2021-2031 (US$ Million)
43. Artificial and Bionic Organs Market, Middle East and Africa, 2021-2031 (US$ Million)
44. Market for artificial and bionic organs of GCC countries, 2021-2031 (millions of dollars)
45. South African bionics and artificial organs market, 2021-2031 (US$ million)
46. Rest of Middle East and Africa Artificial and Bionic Organ Market, 2021-2031 (USD Million)
47. Abbott Laboratories Revenue as of 2019 (US$ million)
48. Revenue from Abiomed Inc. as of 2019 (US$ million)
49. Medtronic Plc Revenue as of 2019 ($M)
50. Boston Scientific Corporation Revenue as of 2019 ($M)
51. Cochlear Limited Sales As of 2019 ($M)
52. Ekso Bionics revenue as of 2019 (US$ million)
53. Zimmer Biomet Revenue as of 2019 ($M)
54. Berlin Heart GmbH revenue, as of 2019 (US$ million)
55. Edward Lifesciences Corporation revenue as of 2019 ($M)
56. Baxter Revenue as of 2019 ($M)
57. Heartware International, Inc. Revenue as of 2019 (US$ million)
58. Iwalk, Inc. Revenue as of 2019 (US$ million)